Vivienne I Rebel Selected Research

Neoplasms (Cancer)

1/2023	Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning.
1/2022	Sputum analysis by flow cytometry; an effective platform to analyze the lung environment.
1/2021	Identification of a novel mechanism for meso-tetra (4-carboxyphenyl) porphyrin (TCPP) uptake in cancer cells.
7/2016	A mechanism for 1,4-Benzoquinone-induced genotoxicity.
9/2015	Early Detection of Lung Cancer with Meso Tetra (4-Carboxyphenyl) Porphyrin-Labeled Sputum.
10/2013	Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
8/2013	Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?
3/2013	Defining a genotoxic profile with mouse embryonic stem cells.
4/2012	Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vivienne I Rebel Research Topics

Disease

9	Neoplasms (Cancer) 01/2023 - 04/2012
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2016 - 04/2012
5	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 04/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2016 - 06/2011
1	Fanconi Anemia (Fanconi's Anemia) 07/2016
1	Lung Neoplasms (Lung Cancer) 09/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2013
1	Melanoma (Melanoma, Malignant) 10/2013
1	Adenocarcinoma 10/2013
1	Genetic Translocation (Chromosomal Translocation) 04/2012
1	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 01/2012
1	Osteopetrosis 01/2012
1	Leukemia 06/2011
1	Down Syndrome (Down's Syndrome) 09/2005
1	Congenital Heart Defects (Congenital Heart Defect) 08/2004
1	Anemia 08/2004

Drug/Important Bio-Agent (IBA)

4	PorphyrinsIBA 01/2023 - 09/2015
3	CREB-Binding ProteinIBA 01/2016 - 01/2012
2	Coloring Agents (Dyes)IBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2023 - 01/2022
2	tetracarboxyphenylporphineIBA 01/2022 - 01/2021
2	DNA Methyltransferase 3AIBA 01/2016 - 01/2015
1	SuspensionsIBA 01/2023
1	ClathrinIBA 01/2021
1	Benzene (Benzole)IBA 07/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2016
1	Complement System Proteins (Complement)IBA 09/2015
1	RNA Precursors (Precursor, mRNA)IBA 10/2013
1	Estrogen ReceptorsIBA 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 08/2013
1	MutagensIBA 03/2013
1	Macrophage Colony-Stimulating FactorIBA 01/2012
1	trioctyl phosphine oxide (TOPO)IBA 06/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 06/2011
1	Carrier Proteins (Binding Protein)IBA 06/2011
1	Adenosine Monophosphate (AMP)IBA 06/2011
1	CyclinsIBA 06/2011
1	Immunoglobulins (Immunoglobulin)IBA 09/2005
1	Cell Adhesion MoleculesIBA 09/2005
1	Protein Isoforms (Isoforms)IBA 09/2005
1	Cyclin D1IBA 08/2004

Therapy/Procedure

4	Therapeutics 01/2021 - 06/2011
1	Aftercare (After-Treatment) 06/2011